PROTACs– a game-changing technology-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PROTACs– a game-changing technology

Published:2019-09-20 Issue:12 Volume:14 Page:1255-1268
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Konstantinidou Markella¹,Li Jingyao¹,Zhang Bidong¹,Wang Zefeng¹,Shaabani Shabnam¹,Ter Brake Frans¹,Essa Khaled¹,Dömling Alexander¹

Affiliation:

1. Drug Design, University of Groningen, Groningen, The Netherlands

Funder

Qatar National Research Foundation

European Lead Factory

ITN ‘Accelerated Early stage drug dIScovery’

National Institute of Health

COFUND ALERT

KWF Kankerbestrijding grant

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2019.1659242

Reference89 articles.

1. Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation

2. Protein-slaying drugs could be the next blockbuster therapies

3. THE UBIQUITIN SYSTEM

4. Waste disposal—An attractive strategy for cancer therapy

5. Oncogenic protein interfaces: small molecules, big challenges

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, SAR, and application of JQ1 analogs as PROTACs for cancer therapy;Bioorganic & Medicinal Chemistry;2024-10

2. Use of Poly(vinyl alcohol) in Spray-Dried Dispersions: Enhancing Solubility and Stability of Proteolysis Targeting Chimeras;Pharmaceutics;2024-07-11

3. Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main Protease;Journal of Medicinal Chemistry;2024-04-12

4. Investigation of the mechanism of USP28-mediated IFITM3 elevation in BCR-ABL-dependent imatinib resistance in CML;Biomedicine & Pharmacotherapy;2024-04

5. Restraining the power of Proteolysis Targeting Chimeras in the cage: A necessary and important refinement for therapeutic safety;Journal of Cellular Physiology;2024-03-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3